IDXX 📈 IDEXX Laboratories - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US45168D1046
IDXX: Diagnostic Kits, Veterinary Instruments, Water Testing Products, Laboratory Analyzers
IDEXX Laboratories, Inc. is a multinational corporation that specializes in developing, manufacturing, and distributing a wide range of products and services for various markets, including companion animal veterinary, livestock and poultry, dairy, and water testing. The company's operations are divided into three main segments: Companion Animal Group, Water Quality Products, and Livestock, Poultry and Dairy. This strategic segmentation enables the company to cater to the diverse needs of its customers across different regions, including Africa, the Asia Pacific, Canada, Europe, Latin America, and other international markets.
The company's product portfolio is extensive and includes point-of-care veterinary diagnostic products, such as instruments, consumables, and rapid assay test kits. These products are designed to provide veterinarians with accurate and reliable diagnostic results, enabling them to make informed decisions about animal health. Additionally, IDEXX Laboratories offers veterinary reference laboratory diagnostic and consulting services, as well as practice management and diagnostic imaging systems and services. These solutions help veterinarians to streamline their workflows, improve patient care, and enhance overall practice management. The company also provides health monitoring, biological materials testing, and laboratory diagnostic instruments and services for the biomedical research community, supporting advancements in human and animal health.
IDEXX Laboratories' product offerings extend to the livestock, poultry, and dairy industries, where the company provides diagnostic and health-monitoring products. These products help farmers and producers to detect and manage diseases, improving the overall health and productivity of their animals. The company's water testing products, such as Colilert, Colilert-18, and Colisure tests, detect the presence of total coliforms and E. coli in water, ensuring the safety of drinking water for humans and animals. Other products, including Enterolert, Pseudalert, Filta-Max, and Quanti-Tray, are used to detect various microbiological contaminants in water. The company also offers point-of-care electrolytes and blood gas analyzers, as well as in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers, providing veterinarians with a comprehensive range of diagnostic tools.
In addition to its animal health and water testing products, IDEXX Laboratories offers veterinary software and services for independent veterinary clinics and corporate groups. These solutions help veterinarians to manage their practices more efficiently, improve patient care, and enhance customer engagement. The company also provides human medical point-of-care products and laboratory diagnostics services, further expanding its reach and capabilities. IDEXX Laboratories' products are marketed through a combination of marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers, ensuring that its products and services are accessible to customers worldwide.
With a history dating back to 1983, IDEXX Laboratories, Inc. is headquartered in Westbrook, Maine, and has established itself as a leading player in the global healthcare industry. The company's common stock is listed on the NASDAQ stock exchange under the ticker symbol IDXX, and its ISIN is US45168D1046. As a member of the Health Care Equipment sub-industry, IDEXX Laboratories is committed to delivering innovative products and services that improve the health and well-being of animals and humans alike. For more information about the company, its products, and services, please visit its website at https://www.idexx.com.
Additional Sources for IDXX Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IDXX Stock Overview
Market Cap in USD | 35,249m |
Sector | Healthcare |
Industry | Diagnostics & Research |
GiC Sub-Industry | Health Care Equipment |
IPO / Inception | 1991-06-21 |
IDXX Stock Ratings
Growth 5y | 13.4% |
Fundamental | 85.6% |
Dividend | - |
Rel. Strength Industry | -821 |
Analysts | 3.64/5 |
Fair Price Momentum | 331.14 USD |
Fair Price DCF | 224.60 USD |
IDXX Dividends
No Dividends PaidIDXX Growth Ratios
Growth Correlation 3m | -75.1% |
Growth Correlation 12m | -86.2% |
Growth Correlation 5y | 25.2% |
CAGR 5y | 9.64% |
CAGR/Mean DD 5y | 0.43 |
Sharpe Ratio 12m | -1.11 |
Alpha | -57.49 |
Beta | 1.24 |
Volatility | 31.51% |
Current Volume | 375k |
Average Volume 20d | 588.6k |
As of December 30, 2024, the stock is trading at USD 414.93 with a total of 375,000 shares traded.
Over the past week, the price has changed by +0.43%, over one month by -1.62%, over three months by -17.87% and over the past year by -25.24%.
Yes, based on ValueRay Fundamental Analyses, IDEXX Laboratories (NASDAQ:IDXX) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 85.63 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IDXX as of December 2024 is 331.14. This means that IDXX is currently overvalued and has a potential downside of -20.19%.
IDEXX Laboratories has received a consensus analysts rating of 3.64. Therefor, it is recommend to hold IDXX.
- Strong Buy: 3
- Buy: 4
- Hold: 6
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, IDXX IDEXX Laboratories will be worth about 370.4 in December 2025. The stock is currently trading at 414.93. This means that the stock has a potential downside of -10.73%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 478.6 | 15.3% |
Analysts Target Price | 569.1 | 37.2% |
ValueRay Target Price | 370.4 | -10.7% |